Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
Agency: Centers for Disease Control and Prevention - ERA
- 93.061 -- Innovations in Applied Public Health Research
Archived opportunityLast Updated: May 13, 2026
View version history on Grants.gov
Description
Eligibility
Eligible applicants
Nonprofit
- Other Native American tribal organizations
- Nonprofits non-higher education with 501(c)(3)
- Nonprofits non-higher education without 501(c)(3)
Education
- Independent school districts
- Public and state institutions of higher education
- Private institutions of higher education
Government
- City or township governments
- Federally recognized Native American tribal governments
- State governments
- Public and Indian housing authorities
- County governments
- Special district governments
Miscellaneous
- Unrestricted
- Other
Additional information
Grantor contact information
Description
HWT0@cdc.gov
Documents
| File name | Description | Last updated |
|---|---|---|
| RFA-TS-23-001_Questions_and_Answers.pdf | Questions and Answers | Dec 14, 2022 04:44 PM UTC |
| RFA-TS-23-001.pdf | RFA-TS-23-001 | Nov 2, 2022 06:39 PM UTC |
| RFA-TS-23-001.pdf | RFA-TS-23-001 Amendment | Dec 21, 2022 03:46 PM UTC |
| 20220810_NOFO_TS23-001_FundingDetrmntn.pdf | 20220810 NOFO_TS23-001 FundingDetrmntn.pdf | Sep 30, 2022 12:48 PM UTC |
| NCEH-ATSDR_Extramural_DMP_Template_0920-1301_Final.docx | NCEH-ATSDR_Extramural_DMP_Template_0920-1301 Final.docx | Sep 30, 2022 12:48 PM UTC |
| RFATS23001_Funding_Determination_11_Aug_2022.pdf | RFATS23001_Funding Determination_11 Aug 2022.pdf | Sep 30, 2022 12:49 PM UTC |
Link to additional information
--
Archived: January 20, 2023
Award
$7,500,000
Program Funding
8
Expected awards
$--
Award Minimum
$500,000
Award Maximum
Funding opportunity number:
RFA-TS-23-001
Cost sharing or matching requirement:
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Health
Category Explanation:
History
Version:
2
Posted date:
September 30, 2022
Archive date:
January 20, 2023
